SEC Form 4 · accession 0000899243-15-005118
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alicia Secor
Officer — Chief Commercial Officer
Period of report
Sep 17, 2015
Accepted (ET)
Sep 21, 2015 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 17, 2015 | M | 25,000 | $9.67 | A | 26,256 | D | |
| Common StockF2,F1 | Sep 17, 2015 | S | 25,000 | $41.05 | D | 1,256 | D | |
| Common StockF2 | Sep 17, 2015 | S | 1,256 | $41.05 | D | 0 | D | |
| Common StockF3 | holding | — | — | — | 4,000 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $9.67 | Sep 17, 2015 | M | 25,000 | D | — | Jan 30, 2024 | Common Stock | 25,000 | 134,235 | D |
Explanation of responses
- F1Includes 647 shares acquired by the Reporting Person under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the "Plan") on June 30, 2015 and 609 shares acquired under the Plan on December 31, 2014.
- F2This sale of shares by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F3These shares are held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein, if any.
- F425% of this option vested January 2, 2015, and the remainder vests in equal monthly installments thereafter over 36 months.